Erythromycin vs. Levaquin: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Erythromycin and Levaquin. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 143,804 people who take Erythromycin and Levaquin, and is updated regularly.
What is Erythromycin?
Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 12,563 Erythromycin users. Check the latest studies of Erythromycin.
What is Levaquin?
Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
143,804 people who take Erythromycin and Levaquin are studied.
Drugs being compared in this study:
- Levaquin (levofloxacin)
- Erythromycin (erythromycin)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Erythromycin:
- not at all: 8.56 %
- somewhat: 29.28 %
- moderate: 33.78 %
- high: 21.17 %
- very high: 7.21 %
Levaquin:
- not at all: 14.29 %
- somewhat: 21.43 %
- moderate: 25.29 %
- high: 31.57 %
- very high: 7.43 %
Want to compare Erythromycin with Levaquin?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Erythromycin (12,069 reports)
- Levaquin (55,020 reports)
Browse all side effects of Erythromycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Levaquin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on erythromycin and levofloxacin (the active ingredients of Erythromycin and Levaquin, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Remicade and Moxifloxacin drug interactions for women aged 50-59 - 32 seconds ago
- Tafinlar and Hair Loss for Women aged 50-59 - 41 seconds ago
- Tafinlar and Hair Thinning for Women aged 50-59 - 41 seconds ago
- Tafinlar and Loss Of Hair for Women aged 50-59 - 41 seconds ago
- Tafinlar and Baldness for Women aged 50-59 - 41 seconds ago
- Tafinlar and Alopecia for Women aged 50-59 - 42 seconds ago
- Tafinlar and Hairloss for Women aged 50-59 - 42 seconds ago
- Norplant vs. Multivitamin, side effect and effectiveness comparison - 48 seconds ago
- Methylphenidate and Zolpidem drug interactions for women aged 40-49 - 49 seconds ago
- Drug interactions of Oxycontin and Xarelto - a minute ago